We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Stenprop Limited | LSE:STP | London | Ordinary Share | GG00BFWMR296 | ORD EUR0.000001258 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 181.75 | 180.00 | 183.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSTP
RNS Number : 8255E
Stenprop Limited
08 July 2019
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALINGS IN SECURITIES BY A DIRECTOR AND BY A DIRECTOR OF MAJOR SUBSIDIARIES OF THE COMPANY
8 July 2019
Shareholders are advised of the following information relating to the exercise of vested nil cost options awarded under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan"):
Name of director: James Beaumont Transaction date: 2 July 2019 Class of securities: Nil cost options Number of securities exercised: 15,228 Deemed total value of the transaction: GBP 16,903.08 (at a deemed value of GBP 1.11 per nil cost option) Nature of transaction: Off-market exercise of nil cost options Nature and extent of director's in terms of the Deferred Bonus Plan interest: Direct beneficial Clearance to deal received: Yes --------------------------------------- --------------------------------------- Name of director of major subsidiaries: Neil Marais Name of major subsidiaries: Stenprop (UK) Limited and Stenprop (Germany) Limited Transaction date: 2 July 2019 Class of securities: Nil cost options Number of securities exercised: 11,903 Deemed total value of the transaction: GBP 13,212.33 (at a deemed value of GBP 1.11 per nil cost option) Nature of transaction: Off-market exercise of nil cost options Nature and extent of director's in terms of the Deferred Bonus Plan interest: Direct beneficial Clearance to deal received: Yes ---------------------------------------- --------------------------------------------
The Company intends to utilise treasury shares to settle the exercise of the nil cost options to the above participants of the Deferred Bonus Plan, following which the total number of treasury shares held by the Company will be 15,948,695 ordinary shares and the total number of shares in issue less shares held in treasury will be 282,826,480 ordinary shares.
For further information:
Stenprop Limited Paul Arenson James Beaumont Julian Carey +44(0)20 3918 6600 Numis Securities Limited (Financial Adviser) Hugh Jonathan Vicki Paine +44(0)20 7260 1000 JSE Sponsor Java Capital Trustees and Sponsors Proprietary Limited + 27 (0) 11 722 3050
About Stenprop
Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHCKFDQBBKDCOK
(END) Dow Jones Newswires
July 08, 2019 09:00 ET (13:00 GMT)
1 Year Stenprop Chart |
1 Month Stenprop Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions